Announcements Trials
Browse Landscape

Phase

Phase NA 114Phase 2 24Phase 3 15Phase 4 7Phase 1 7Phase EARLY_PHASE1 3Phase 2/3 2Phase 1/2 2

Status

Recruiting 4Unknown 3Completed 2Withdrawn 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 1Muscular Atrophy 1Mouth Neoplasms 1Child Nutrition Disorders 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Standard of Care × Clear all
NCT06175273 2025-09-18

POINT

University of Kentucky

Phase 2/3 Completed
19 enrolled

Muscular Atrophy, Neoplasms, Child Nutrition Disorders

NCT05865548 2024-08-13

Addition of Aspirin to Standard of Care in Oral Cancer

Banaras Hindu University

Phase 2/3 Completed
60 enrolled
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡